BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21130514)

  • 1. Altered nerve excitability in subclinical/early diabetic neuropathy: evidence for early neurovascular process in diabetes mellitus?
    Bae JS; Kim OK; Kim JM
    Diabetes Res Clin Pract; 2011 Feb; 91(2):183-9. PubMed ID: 21130514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral nerve excitability measures at different target levels: the effects of aging and diabetic neuropathy.
    Shibuta Y; Nodera H; Mori A; Okita T; Kaji R
    J Clin Neurophysiol; 2010 Oct; 27(5):350-7. PubMed ID: 20844439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV; Lin CS; Kiernan MC
    Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve excitability properties in early preclinical diabetic neuropathy.
    Erdoğan C; Yücel M; Değirmenci E; Öz O; Akgün H; Odabaşı Z
    Diabetes Res Clin Pract; 2011 Oct; 94(1):100-4. PubMed ID: 21741106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison between Dyck's criteria and the polyneuropathy index-revised (PNI-R) in the electrophysiologic evaluation of diabetic neuropathy].
    Hasegawa O; Matsumoto S; Gondo G; Wada N; Arita T
    No To Shinkei; 2001 Nov; 53(11):1015-9. PubMed ID: 11761909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.
    Sawai S; Kanai K; Nakata M; Hiraga A; Misawa S; Isose S; Hattori T; Kuwabara S
    Clin Neurophysiol; 2008 May; 119(5):1097-105. PubMed ID: 18342570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polyneuropathy index-revised in the evaluation of diabetic neuropathy].
    Hasegawa O; Matsumoto S; Gondo G; Arita T
    No To Shinkei; 2001 Mar; 53(3):259-63. PubMed ID: 11296400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral sensory nerve dysfunction in children and adolescents with type 1 diabetes mellitus.
    Barkai L; Kempler P; Vámosi I; Lukács K; Marton A; Keresztes K
    Diabet Med; 1998 Mar; 15(3):228-33. PubMed ID: 9545124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of age on excitability properties in human motor axons.
    Bae JS; Sawai S; Misawa S; Kanai K; Isose S; Shibuya K; Kuwabara S
    Clin Neurophysiol; 2008 Oct; 119(10):2282-6. PubMed ID: 18760964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.
    Kanai K; Kuwabara S; Misawa S; Tamura N; Ogawara K; Nakata M; Sawai S; Hattori T; Bostock H
    Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in measures of motor axon excitability with age.
    Jankelowitz SK; McNulty PA; Burke D
    Clin Neurophysiol; 2007 Jun; 118(6):1397-404. PubMed ID: 17452010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
    Kamenov ZA; Petrova JJ; Christov VG
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible contribution of adipocytokines on diabetic neuropathy.
    Matsuda M; Kawasaki F; Inoue H; Kanda Y; Yamada K; Harada Y; Saito M; Eto M; Matsuki M; Kaku K
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S121-3. PubMed ID: 15563961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve excitability properties in lower-limb motor axons: evidence for a length-dependent gradient.
    Krishnan AV; Lin CS; Kiernan MC
    Muscle Nerve; 2004 May; 29(5):645-55. PubMed ID: 15116367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral neuropathy in children with insulin-dependent diabetes mellitus.
    Fiçicioğlu C; Aydin A; Haktan M; Kiziltan M
    Turk J Pediatr; 1994; 36(2):97-104. PubMed ID: 8016923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strength-duration properties in diabetic polyneuropathy.
    Yerdelen D; Koç F; Uysal H; Sarica Y
    Diabetes Res Clin Pract; 2007 Oct; 78(1):56-9. PubMed ID: 17408800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the medullary reactivity, excitability and conductivity of the peripheral nerves of a diabetic without clinical neurological alterations].
    Pendefunda L
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(1):95-104. PubMed ID: 545590
    [No Abstract]   [Full Text] [Related]  

  • 18. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients.
    Lozeron P; Nahum L; Lacroix C; Ropert A; Guglielmi JM; Said G
    J Neurol; 2002 May; 249(5):569-75. PubMed ID: 12021947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of peripheral nerve conduction in diabetic neuropathy with subclinical left ventricular systolic dysfunction.
    Mochizuki Y; Tanaka H; Matsumoto K; Sano H; Toki H; Shimoura H; Ooka J; Sawa T; Motoji Y; Ryo K; Hirota Y; Ogawa W; Hirata K
    Cardiovasc Diabetol; 2015 May; 14():47. PubMed ID: 25946999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of the blink reflex in the early diagnosis of cranial nerve neuropathy associated with diabetes mellitus.
    Al-Azzawi LM; Mirza Kb; Kummoona R
    Electromyogr Clin Neurophysiol; 2004 Sep; 44(6):323-7. PubMed ID: 15473343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.